The basis for use of β-adrenergic blockers in congestive heart failure (CHF) is

A) They exert positive inotropic effect in CHF B) They counteract deleterious effect of sympathetic overactivity on the myocardium C) They exert antiischaemic effect on the heart D) They prevent cardiac arrhythmias